The Low Impact of Accounting Information about Intangible Assets in the Valuation of Innovative Spanish Companies: The Case of Pharmaceutical and Biotechnology Industry

Authors

  • Gracia Rubio Martín Departamento de Economía Financiera y Contabilidad III Universidad Complutense de Madrid (España)
  • Mercedes Rodríguez Paredes Departamento de Economía Financiera y Contabilidad II Universidad Complutense de Madrid (España)
  • Juan Antonio Maroto Acín Departamento de Economía Financiera y Contabilidad III Universidad Complutense de Madrid (España)

DOI:

https://doi.org/10.46661/revmetodoscuanteconempresa.2181

Keywords:

Intangible, generador de valor, valor razonable, informe de capital intelectual, intangible, value driver, fair value, intellectual capital report

Abstract

This article analyzes the extent to which accounting standards adequately reflects the value of intangible assets as well as its usefulness for financial agents in the process of buying and selling companies. Based on a sample that includes price of private transactions and listed companies from the pharmaceutical and biotech Spanish sector in the period 2005-2011, we have analyzed: i) The performance of price-to-book ratio; and ii) Based on a regression model, the relevance of different accounting items in the price generation process, as well as what part of the intangible value of the company is not reflected in the financial statements. The authors conclude that traditional financial information must be complemented with an intellectual capital report. 

Downloads

Download data is not yet available.

References

ABOODY, D. y LEV, B. (1998): “The Value Relevance of Intangibles: The Case of Software Capitalization”. Journal of Accounting Research, 36, pp. 161–191.

ABOODY, D. y LEV, B. (2001): R&D Productivity in the Chemical Industry, New York (disponible en www.baruch-lev.com).

AHMED, K. y FALK, H. (2006): “The value relevance of management's research and development reporting choice: evidence from Australia”. Journal of Accounting and Public Policy, 25 (3), pp. 231–264.

AICPA (2011): Assets acquired to be used in research and development activities, American Institute of Certified Public Accountants, New York, USA.

AMIR, E. y LEV, B. (1996): “Value-relevance of nonfinancial information: the wireless communications industry”, Journal of Accounting and Economics, 22, pp. 3–30.

BARTH, M.E y CLINCH, G. (2009): “Scale Effects in Capital Markets-Based Accounting Research”. Journal of Business Finance & Accounting, 36(3) & (4), pp. 253–288.

BARTH, M.E. y KALLAPUR, S. (1996): “The effects of Cross-Sectional Scale Differences on Regressions Results in Empirical Accounting Research”. Contemporary Accounting Research, Vol. 13, pp. 527–567.

BROWN, S., LO, K. y LYS, T. (1999): “Use of R2 in accounting research: Measuring changes in value relevance over the last four decades”. Journal of Accounting and Economics, 28, pp. 83–115.

COLLINS, D.W., MAYDEW, E.L. y WEISS, I.S. (1997): “Changes in the value-relevance of earnings and book values over the past forty years”. Journal of Accounting and Economics, 24, pp. 39–67.

CORE, J., GUAY, W. y VAN BUSKIRK, A. (2003): “Market valuations in the New Economy: An investigation of what has changed”. Journal of Accounting and Economics, 34, pp. 43– 67.

CHOIW, W.; KWONS, S. y LOBOG, J. (2000): “Market valuation of Intangible Assets”, Journal of Business Research, 49, pp. 35–45.

CHOW, G.C. (1960): “Tests of equality between sets of coefficients in two linear regressions”, Econometrica, Nº 28 (3), pp. 591–605.

CHUNG, K. y PRUIT, S. (1994): “A simple approximation of Tobin's q”, Financial Management, Vol. 23, Nº 3, Autumn, pp. 70–74.

DAMODARAN, A. (2006): Damodaran on valuation: security analysis for investment and corporate finance, 2ª ed., John Wiley & Sons, New Jersey, USA.

DAMODARAN ONLINE: Updated data. Europe 2011. Disponible en: www.damodaran.com.

DANTOH, A., RADHAKRISHNAN, S. y RONEN, J. (2004): “The declining value-relevance of accounting information and non-information-based trading: An empirical analysis”. Contemporary Accounting Research, 21 (4), pp. 795–812.

EASTON, P. y SOMMERS, G. (2003): “Scale and the Scale Effect in Market-based Accounting Research”. Journal of Business, Finance & Accounting, Vol. 30, pp. 25–56.

FRANCIS, J. y SCHIPPER, K. (1999): “Have financial statements lost their relevance?”. Journal of Accounting Research, 37 (2), pp. 319–352.

GLEASON, K. y KLOCK, M. (2006): “Intangible capital in the pharmaceutical and chemical industry”, The Quarterly Review of Economics and Finance, 46, pp. 300–314.

GORDON, M. (1962): The Investment, Financing and Valuation of the Corporation, Irwin&Co, Illinois, USA.

GU, Z. (2005): “Scale Factor, R2, the Choice of Levels versus Returns Models”, Journal of Accounting, Auditing, & Finance, Vol. 20, Issue 1 (Winter), pp. 71–91.

GUTIÉRREZ DE MESA VÁZQUEZ, E. y RUBIO MARTÍN, G. (2006): “La valoración de los activos intangibles en la empresa biofarmacéutica: Una reflexión crítica sobre la aplicación de las NIIF”. Partida Doble (178), pp. 18–30.

ÍÑIGUEZ, R. y LOPEZ, G. (2005): “Valoración de los activos intangibles en el mercado de capitales español”, Revista Española de Financiación y Contabilidad, Vol. XXXIV, Nº 125, abril-junio, pp. 459–499.

LARRÁN, J.M., y SOTOMAYOR, S. (2005): “Valoración y reconocimiento de activos intangibles”. Revista Internacional Legis de Contabilidad y Auditoría, 21, enero-marzo, pp. 83–128.

LEV, B. (1989): “One the Usefulness of Earning and Earning research: Lessons and directions from Two Decades of Empirical Research”. Journal of accounting research, Vol. 27, pp. 153–193.

LEV, B. (2000): Knowledge and Shareholder Value: Working Paper, Stern School of Business, New York University, New York, USA.

LEV, B. (2005): “Intangible Assets: Concepts and Measurements”, Encyclopedia of Social Measurement, Vol. 2, pp. 299–305.

LEV, B. y ZAROEIN, P. (1999): “The boundaries of financial reporting and how to extend them”. Journal of Accounting Research, 37 (2), pp. 353–385.

LIANG, C.J. y YAO, M.L. (2005): “The value-relevance of financial and nonfinancial information—Evidence from Taiwan's information electronics industry”. Review of Quantitative Finance and Accounting, 24, pp. 135–175.

MALKIEL, B.G. (2008): Un paseo aleatorio por Wall Street, 9ª ed., Alianza Editorial, Madrid.

NIIF 3, 13, NIC 36 y 38, International Accounting Standards Board (IASB). www.ifrs.org.

OHLSON, J. (1995): “Earnings, book values and dividends in equity valuation”, Contemporary Accounting Research, Vol. 11, Nº 2, Spring, pp. 661–687.

OSWALD, D.R. (2008): “The determinants and value relevance of the choice of accounting for research and development expenditures in the United Kindom”, Journal of Business Finance & Accouting, 35 (1) & (2), January-March, pp. 1–24.

OSWALD, D.R. y ZAROWIN, P. (2007): “Capitalization of R&D and the Informativeness of Stock Prices”. European Accounting Review, 16, pp. 703–726.

PRICE WATER HOUSE COOPERS (2006): A review of the implementation of IRFS in the pharmaceuticals industry, Price Water House Coopers, Madrid.

RUBIO, G. y LAMOTHE, P. (2010): “Valoración de las grandes corporaciones farmacéuticas, a través del análisis de sus principales intangibles, con el método de opciones reales”, Revista de Economía Financiera, pp. 47–74.

RUBIO, G., SOUSA, S. y MAROTO, J.A. (2012): “El valor razonable de la innovación en los estados financieros de las empresas farmacéuticas y biotecnológicas: la necesidad de elaborar un informe de capital intelectual”. Revista Contable, Nº 5.

SHARPE, W. (1970): “Porfolio Theory and Capital Market”. McGraw Hill, USA.

SHILLER, R. (2001): Irrational exuberance, Broadway Books, USA.

STERN, J.M., y SHIELY J. (2005): El reto del EVA. 1ª edición, Editorial 2000, Barcelona.

TOBIN, J. (1969): “A general equilibrium approach to monetary theory, Q- de Tobin”. Journal of Money, Credit & Banking, Vol. 1, pp.15–29.

TUTTICCI, I., KRISHMAN, G. y PERCY, M. (2007): “The role of external monitoring in firm valuation: The case of R&D capitalization”. Journal of International Accounting Research, 62, pp. 83–107.

WHITE, H. (1980): “A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity”. Econometrica, Vol. May, pp. 817–838.

ZÉGHAL, D. y MAALOUL, A. (2011): “The accounting treatment of intangibles – A critical review of the literature”. Accounting Forum Vol. 35, No. 4, pp. 262–274.

Published

2016-11-04

How to Cite

Rubio Martín, G., Rodríguez Paredes, M., & Maroto Acín, J. A. (2016). The Low Impact of Accounting Information about Intangible Assets in the Valuation of Innovative Spanish Companies: The Case of Pharmaceutical and Biotechnology Industry. Journal of Quantitative Methods for Economics and Business Administration, 16, Páginas 68 a 94. https://doi.org/10.46661/revmetodoscuanteconempresa.2181

Issue

Section

Articles